Clinical manifestations of psychiatric patients who are carriers of tay-sachs disease. Possible role of psychotropic drugs.

Zelnik, N; Khazanov, V; Sheinkman, A; Karpati, A M; Peleg, L

Zelnik, N; Khazanov, V; Sheinkman, A; Karpati, A M; Peleg, L.

Affiliation

Zelnik N; Department of Pediatrics, Carmel Hospital and the B. Rappaport Faculty of Medicine, Technion, Haifa, Israel. Zelnik@ibm.net

Neuropsychobiology ; 41(3): 127-31, 2000.

Article in En | MEDLINE | ID: mdl-10754426

Subject(s)

Cognition Disorders/epidemiology; Genetic Carrier Screening/methods; Heterozygote; Psychotic Disorders/epidemiology; Tay-Sachs Disease/epidemiology; Tay-Sachs Disease/genetics; Cognition Disorders/diagnosis; Comorbidity; DNA Mutational Analysis; Female; Humans; Logistic Models; Male; Middle Aged; Neuropsychological Tests; Prevalence; Psychotic Disorders/blood; Psychotic Disorders/diagnosis; Risk Assessment; Tay-Sachs Disease/blood; beta-N-Acetylhexosaminidases/blood; beta-N-Acetylhexosaminidases/genetics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Tay-Sachs Disease / Cognition Disorders / Heterozygote / Genetic Carrier Screening Type of study: Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Neuropsychobiology Year: 2000 Document type: Article Affiliation country: Israel Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links